Upgrade to SI Premium - Free Trial

Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $22 at BofA Securities

April 28, 2026 12:18 PM
BofA Securities analyst Jason M. Gerberry raised the price target on Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) to $22.00 (from $19.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change